Literature DB >> 13479846

Control of ethyl biscoumacetate (tromexan) therapy by standardized clotting time of whole blood.

G A MAYER, W F CONNELL.   

Abstract

Entities:  

Keywords:  ETHYL BISCOUMACETATE/administration

Mesh：

Substances：

Year:  1957        PMID： 13479846      PMCID： PMC1824203     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis.

Authors:  S WESSLER
Journal:  J Clin Invest       Date:  1955-04       Impact factor: 14.808

2.  The control of tromexan therapy.

Authors:  J H OLWIN; I A FRIEDMAN
Journal:  Surg Gynecol Obstet       Date:  1954-07

3.  Pharmacology of bis 3-3'-(4 oxycoumarinyl) ethyl acetate (tromexan).

Authors:  M STIRLING; R B HUNTER
Journal:  Lancet       Date:  1951-10-06       Impact factor: 79.321

4.  Tromexan-3,3'-carboxymethylenebis (4-hydroxycoumarin) ethyl ester; experimental and clinical properties.

Authors:  G E BURKE; I S WRIGHT
Journal:  Circulation       Date:  1951-02       Impact factor: 29.690

5.  Effect of bishydroxycoumarin (dicumarol) on clotting time of whole blood.

Authors:  G A MAYER; W F CONNELL
Journal:  J Am Med Assoc       Date:  1956-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.